Corporate
2015.10.05
Lumosa attends STAIRS IX
Lumosa Therapeutics was invited to take part in the ninth Stroke Treatment Academic Industry Roundtable (STAIR IX), held on October 5-6, 2015 in Bethesda, Maryland, USA. STAIR is the first, and so far, the only global-scaled industrial, governmental, and academic platform dedicated to the treatment of cerebral stroke. Lumosa is the first new drug development company from Taiwan to participate in this event. Lumosa's representatives participated in workshops addressing various hot topics in current stroke treatments, and will be the contributors of position papers to be published in the near future. Lumosa plans to adopt the new learning and establish them in its development plan for its leading stroke program, LT3001.
STAIR IX Link
STAIR IX Link
